Skip to main content
. 2018 Aug 2;2018(8):CD010966. doi: 10.1002/14651858.CD010966.pub2

13.4. Analysis.

13.4

Comparison 13 Tezacaftor (100 mg once daily) plus ivacaftor (150 mg twice daily) versus either placebo or ivacaftor (150 mg twice daily) alone, Outcome 4 Most common adverse events (occurring in at least 10% of participants in either group).